Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 4:01 pm Sale | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 481,727 4.68% | -117,470 (-19.60%) | View |
| 2024-03-20 9:07 pm Sale | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 599,197 5.83% | -90,372 (-13.11%) | View |
| 2023-12-27 4:07 pm Unchanged | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 7.12% | 0 (Unchanged) | View |
| 2023-08-30 5:16 pm Unchanged | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 8.16% | 0 (Unchanged) | View |
| 2023-06-12 4:01 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 7.11% | 689,569 (New Position) | View |
| 2023-06-02 5:12 pm Purchase | 13D | ROTH CH ACQUISITION IV CO COM ROCG | Clal Biotechnology Industries Ltd. | 4,584,422 7.88% | 4,584,422 (New Position) | View |